articles like this annoy me a bit (even though I'm sharing it here) because everyone posts it as some kind of "AI is useless" gotcha. It doesnt help that WSJ is paywalled, so as is always the case, pharmaceutical companies are of course using AI fully (and IMO correctly), just not the way OpenAI et al claim it can do the work all on its own:
> Drugmakers are certainly using AI—even to create new drugs. It is helping researchers pick targets, fine-tune experimental medicines and identify which patients would be good candidates for the treatments. Leiden says it is useful as a scientist’s co-pilot.
> Drugmakers are certainly using AI—even to create new drugs. It is helping researchers pick targets, fine-tune experimental medicines and identify which patients would be good candidates for the treatments. Leiden says it is useful as a scientist’s co-pilot.
"Drugmaker CEOs plan to use AI to 'manage disease' not 'cure' it."